EV/EBITDA:
11.12-0.06(-0.54%)Summary
- As of today (June 22, 2025), HALO EV/EBITDA is 11.12, with a fall of -0.06 (-0.54%) during the most recent trading session on June 20, 2025.
- Over the past year, HALO EV/EBITDA has dropped by -4.79 (-30.11%).
- HALO EV/EBITDA is now -99.65% below its all-time high of 3163.18.
Performance
HALO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
HALO EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -0.5% | -0.5% | -0.6% |
1 m1 month | -1.1% | -1.0% | -1.2% |
3 m3 months | -15.6% | -15.5% | -17.9% |
6 m6 months | -11.5% | +7.5% | +12.5% |
ytdytd | - | - | +10.5% |
1 y1 year | -30.1% | -0.5% | +3.8% |
5 y5 years | +119.3% | +117.5% | +116.1% |
HALO EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | 11.69 | -4.9% | 11.12 | at low |
3 m | 3-month | 14.16 | -21.5% | 10.27 | +8.3% |
6 m | 6-month | 14.16 | -21.5% | 10.27 | +8.3% |
1 y | 1-year | 18.37 | -39.5% | 10.27 | +8.3% |
3 y | 3-year | 32.43 | -65.7% | 10.27 | +8.3% |
5 y | 5-year | 140.85 | -92.1% | -218.09 | +105.1% |
alltime | all time | 3163.18 | -99.7% | -218.09 | +105.1% |
HALO EV/EBITDA History
Date | Value |
---|---|
2025 | 11.12(-17.1%) |
2023 | 13.42(-52.7%) |
2022 | 28.36(+16.9%) |
2021 | 24.27(-38.3%) |
2020 | 39.33(-182.2%) |
2019 | -47.85(+30.0%) |
2018 | -36.82(-207.9%) |
2017 | 34.13(-289.8%) |
2016 | -17.98(-79.5%) |
2015 | -87.86(+346.2%) |
Date | Value |
---|---|
2014 | -19.69(-10.6%) |
2013 | -22.02(+68.0%) |
2012 | -13.11(-73.8%) |
2011 | -50.13(+270.8%) |
2010 | -13.52(+63.7%) |
2009 | -8.26(+4.0%) |
2008 | -7.94(-52.0%) |
2007 | -16.55(-50.1%) |
2006 | -33.19(+389.5%) |
2005 | -6.78(-34.1%) |
2004 | -10.29 |
FAQ
- What is Halozyme Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Halozyme Therapeutics?
- What is Halozyme Therapeutics EV/EBITDA year-on-year change?
What is Halozyme Therapeutics EV/EBITDA?
The current EV/EBITDA of HALO is 11.12
What is the all time high EV/EBITDA for Halozyme Therapeutics?
Halozyme Therapeutics all-time high EV/EBITDA is 3163.18
What is Halozyme Therapeutics EV/EBITDA year-on-year change?
Over the past year, HALO EV/EBITDA has changed by -4.79 (-30.11%)